CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 414 filers reported holding CRISPR THERAPEUTICS AG in Q4 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $318,233 | -19.2% | 7,011 | 0.0% | 0.09% | -17.1% |
| Q2 2023 | $393,671 | +22.1% | 7,011 | -1.7% | 0.11% | +16.8% |
| Q1 2023 | $322,492 | +1079.3% | 7,130 | -7.8% | 0.10% | +41.8% |
| Q4 2022 | $27,347 | -99.9% | 7,730 | 0.0% | 0.07% | -35.6% |
| Q3 2022 | $43,593,000 | -1.1% | 7,730 | 0.0% | 0.10% | +4.0% |
| Q2 2022 | $44,088,000 | -0.1% | 7,730 | -2.5% | 0.10% | +3.1% |
| Q1 2022 | $44,115,000 | +0.4% | 7,930 | +3.5% | 0.10% | -3.0% |
| Q4 2021 | $43,953,000 | +0.4% | 7,660 | +104.3% | 0.10% | -1.0% |
| Q3 2021 | $43,779,000 | +11.4% | 3,750 | +28.9% | 0.10% | +11.0% |
| Q2 2021 | $39,285,000 | +32.9% | 2,910 | +3.6% | 0.09% | +16.7% |
| Q1 2021 | $29,557,000 | -3.5% | 2,810 | +836.7% | 0.08% | -7.1% |
| Q4 2020 | $30,637,000 | +22.1% | 300 | -25.0% | 0.08% | +663.6% |
| Q3 2020 | $25,100,000 | +13.7% | 400 | -34.6% | 0.01% | -15.4% |
| Q2 2020 | $22,069,000 | -13.3% | 612 | -29.0% | 0.01% | -23.5% |
| Q1 2020 | $25,457,000 | +636325.0% | 862 | +762.0% | 0.02% | – |
| Q2 2019 | $4,000 | -99.9% | 100 | 0.0% | 0.00% | -100.0% |
| Q4 2018 | $2,857,000 | -32.5% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $4,234,000 | -29.5% | 100 | 0.0% | 0.00% | -50.0% |
| Q2 2018 | $6,005,000 | +130.3% | 100 | 0.0% | 0.00% | +100.0% |
| Q4 2017 | $2,607,000 | +32.3% | 100 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $1,970,000 | +22.9% | 100 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,603,000 | -19.2% | 100 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $1,985,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $31,294,000 | 31.24% |
| NEA Management Company, LLC | 1,590,002 | $365,593,000 | 10.56% |
| Ariose Capital Management Ltd | 37,900 | $2,379,000 | 9.30% |
| ARK Investment Management | 9,404,071 | $590,294,000 | 2.46% |
| NIA IMPACT ADVISORS, LLC | 80,082 | $5,027,000 | 2.44% |
| Nikko Asset Management Americas, Inc. | 4,619,747 | $291,044,000 | 2.14% |
| PLUSTICK MANAGEMENT LLC | 50,000 | $3,139,000 | 1.98% |
| Integral Health Asset Management, LLC | 120,000 | $7,532,000 | 1.96% |
| Valiant Capital Management, L.P. | 240,683 | $15,108,000 | 1.73% |
| Deuterium Capital Management, LLC | 18,000 | $1,130,000 | 1.45% |